Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Marker processes in survival analysis

N P Jewell1, J D Kalbfleisch

  • 1Department of Statistics, University of California, Berkeley 94720, USA.

Lifetime Data Analysis
|January 1, 1996
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Misclassified group-tested current status data.

Biometrika·2018
Same author

Planning for Uncertainty and Fallbacks Can Increase the Number of Transplants in a Kidney-Paired Donation Program.

American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons·2015
Same author

A Perspective on the Scientific Registry of Transplant Recipients' Migration to Bayesian Methods.

American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons·2015
Same author

Bronchoalveolar lavage cell immunophenotyping facilitates diagnosis of lung allograft rejection.

American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons·2014
Same author

Access and outcomes among minority transplant patients, 1999-2008, with a focus on determinants of kidney graft survival.

American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons·2010
Same author

Innovations in the assessment of transplant center performance: implications for quality improvement.

American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons·2009
Same journal

Shared frailty sieve estimation for dependent left truncated and interval censored data.

Lifetime data analysis·2026
Same journal

Functional win-fractions regression models for composite outcomes.

Lifetime data analysis·2026
Same journal

Variable selection in causal semiparametric transformation models with all-or-nothing treatment compliance.

Lifetime data analysis·2026
Same journal

Correction to: A uniformisation-driven algorithm for inference-related estimation of a phase-type ageing model.

Lifetime data analysis·2026
Same journal

Unobserved heterogeneity in threshold regression based on the hitting times of a reflected Brownian motion for recurrent hypoglycemia.

Lifetime data analysis·2026
Same journal

Variable selection with broken adaptive ridge regression for interval-censored competing risks data.

Lifetime data analysis·2026
See all related articles

This study introduces a statistical model using marker processes to predict disease progression and survival time. Utilizing marker data can improve the efficiency of survival distribution estimation and risk prediction.

Area of Science:

  • Biostatistics
  • Survival Analysis
  • Medical Statistics

Background:

  • Disease progression is often monitored by stochastic variables known as marker processes.
  • Marker processes can provide insights into current hazard rates and remaining time to failure.

Purpose of the Study:

  • To develop a statistical model for the relationship between hazard function and marker process history.
  • To explore statistical applications of markers for survival distribution estimation.
  • To assess the efficiency gains from incorporating marker process information.

Main Methods:

  • An additive model is proposed for the hazard function based on marker process history.
  • Statistical calculations are developed for the proposed model.
  • Methods address censored data and prevalent individuals.

Related Experiment Videos

Main Results:

  • The model facilitates estimation of survival distributions using marker data.
  • Markers can serve as surrogate endpoints for failure in survival analysis.
  • Markers can predict time since onset in prevalent cases.

Conclusions:

  • The proposed marker process model offers a framework for enhanced survival analysis.
  • Utilizing marker information can lead to more efficient estimation and prediction.
  • This approach has implications for clinical trial design and patient risk stratification.